Related Experiment Video
Updated: May 9, 2026

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
Cytochalasins from the marine-derived fungus Acremonium implicatum DFFSCS001 and their anti-inflammatory activities
Yu-Qian Tang1, Chu-Xing Liang2, Hui Cui2
1CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, 164 West Xingang Road, Guangzhou, 510301, Guangdong, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
Abstract:
Nine undescribed cytochalasins, acrechalasins A‒I, together with three known analogs 21-O-deacetyl-L-696,474 and diaporthichalasins B and A were isolated from the marine-derived fungus Acremonium implicatum DFFSCS001. Their structures were elucidated by spectroscopic methods, and the absolute configurations of acrechalasins C and D and diaporthichalasin B were determined by single-crystal X-ray diffractions. Among them, acrechalasins A and B had a rare open-chain cytochalasin skeleton with a monocyclic butyrolactam group. Biologically, acrechalasins A‒I and 21-O-deacetyl-L-696,474 exhibited significant inhibitory activity against lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells with IC50 values ranging from 1.30 to 20.31 μM. Their structure-bioactivity relationship was also discussed. Especially, acrechalasins A and D also significantly suppressed the protein expression of iNOS at the concentration of 10 μM. This is the first report on the anti-inflammatory activities of open-chain cytochalasins featuring a monocyclic butyrolactam group.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Antifungal Agents

